SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-147017
Filing Date
2024-05-24
Accepted
2024-05-24 16:03:08
Documents
13
Period of Report
2024-05-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d810940d8k.htm   iXBRL 8-K 30252
  Complete submission text file 0001193125-24-147017.txt   157138

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA phat-20240523.xsd EX-101.SCH 2869
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE phat-20240523_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phat-20240523_pre.xml EX-101.PRE 11720
16 EXTRACTED XBRL INSTANCE DOCUMENT d810940d8k_htm.xml XML 3775
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39094 | Film No.: 24984165
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)